• Register

INJEX Pharma GmbH signs first contract with Kuwait in Middle East

Kuwait: Sunday, December 04 - 2011 @ 14:40

In Middle East the diabetes rate is among the highest in the world. The people do not have enough exercise, people smoke, obesity is increased and nutrition sweet and unhealthy. Africa, the Middle East and India have the highest increasing prevalence worldwide.

The Al Shamali Group signed pre contracts for other countries in Middle East. The registration for the product is expected short term. The pharmaceutical division manager Dr. Wael A. Elghamri is responsible for the market introduction.

Al-Shamali Group for General Trading & Contracting was established in Kuwait City, the State of Kuwait in 1992. Over the past two decades it has grown from its humble sole focus on construction to a very diverse group of companies encompassing International Investment, Medical & Pharmaceuticals.”

Mr. Ali A. Reda, the General Manager for Al-Shamali Group Co. stated that “Injex is a unique instrument that will make a big difference and a relief from needle shots for Diabetic patients in Kuwait and other countries in the region. As one patient feedback after receiving and testing a starter kit sample was “IT IS A MAGIC”

Dr. Wael A. Elghamri, Pharmaceutical Division Manager (Boubyan Medical), stated: “From our studying in our area diabetes rate is among the highest in the world, we have more than 20% of population is patients with diabetes, more than 18% of them insulin dependent, In addition to other uses of injex30 as immunization, local anesthesia and meso – therapy. So we expect very high sales at launch.”

Andy Rösch, CEO of Paketeria AG (Injex Pharma AG): “We are very convinced that this agreement is just the very first step with the INJEX30, made in Germany, into the Middle East Area. We have a lot of other interested companies form Middle East, who are interested to market our needle free syringe. Last week we trained directly after MEDICA our potential new partner for Saudi Arabia and we expect the contract to be signed before Christmas “

INJEX Pharma GmbH shall be merged by 100 % into Paketeria AG, listed at the Frankfurt Stock Exchange, which is the main resolution on the Annual Meeting of December 16th 2011 in Berlin. Paketeria AG will have the new company name INJEX Pharma AG.

Today's Top Stories

Posted by

Sunday, December 4- 2011 @ 14:40 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.

AME Info Services

Business DirectoryVIEW ALL

Search by name

Search by industry

Browse alphabetically


Search for jobs

Latest Jobs